Sun-21-06-2015, 11:01 AM
(Sun-21-06-2015, 07:01 AM)Quest4Cure Wrote: I have read where the gene marker for PSA has been Identified. Scientists have found a PSA gene marker on what is called a locus. A specific place on a chromosome where genetic variations happen. Scientisits have found a genetic variation or gene marker for psoriatic arthritis on a locus on chromosome 5. Scientists found this marker to make a patient prone to PSA and not Psoriasis. Now it's narrowed down to the IL-23 monoclonal antibody drug is the next step for research for PsA.
Merck highlites R&D of anti-interleukin-23
(Sun-21-06-2015, 07:01 AM)Quest4Cure Wrote: Also another med for Psoriasis has been approved in the U.S. IL-17a interleukin pathway 17-A
Secukinumab, a fully human anti-interleukin-17A monoclonal antibody for P. & PSA. Hope it's available for you. I read it can clear P. Patients with 40%-60% coverage in 3-4 weeks.
Yes we have a lot of information on Cosentyx and it's in our list of Biological Treatments For Psoriasis
As for trials I nearly went on the ASP015K one, but didn't get it because I had been using Bio's for to long. But trials are not something I would normaly go for, and if I did it would be through my hospital.